Xenodiagnosis After Antibiotic Treatment for Lyme Disease
NCT02446626 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72
Last updated 2024-06-03
Summary
Background:
The most common tick-borne illness in the United States, Lyme disease is caused by Borrelia burgdorferi bacteria that are transmitted to people by Ixodes scapularis ticks. Most cases of Lyme disease are cured by antibiotics, but some patients continue to experience symptoms despite the absence of detectable Lyme bacteria. Xenodiagnosis uses a vector to detect the presence of a disease-causing microbe. Researchers will use live, laboratory-bred ticks to see if Lyme disease bacteria can be detected in people after completing antibiotic therapy and if that is more common in people who continue to experience symptoms such as fatigue and joint pain.
Objectives:
\- To see if ticks can be used to detect B. burgdorferi in people who have had Lyme disease and received antibiotic therapy and if it correlates with persistent symptoms.
Eligibility:
* Adults at least 18 years old who have:
* Untreated erythema migrans (the Lyme disease rash); OR
* Untreated Lyme arthritis; OR
* Continuing symptoms after treatment for Lyme disease; OR
* Had Lyme disease and antibiotic treatment within the past 12 months.
* Healthy volunteers
Design:
* Participants will be screened with medical history, physical exam, and blood tests.
* Visit 1:
* Blood and urine tests, health questionnaire.
* Up to 30 laboratory-bred, pathogen-free, larval ticks (each smaller than a poppy seed) will be placed under a dressing.
* Participants may have two small biopsies of skin .
* 4 6 days later, Visit 2:
* Dressing will be removed and ticks will be collected.
* Participants will answer symptom questions.
* If many ticks are still attached, participants will have to come back the next day. If not enough ticks feed successfully, the procedure may be repeated.
* Participants will keep a diary of symptoms for 30 days. Over 3 months, they will be return to the clinic 3 times to see how they feel and answer questionnaires. Test results will be discussed.
Conditions
- Lyme Disease
Interventions
- PROCEDURE
-
Skin biopsy
Optional 2-3mm skin punch biopsies will be performed.
- PROCEDURE
-
Blood draw
Peripheral blood draws will be performed.
- DEVICE
-
Xenodiagnosis
Larval ticks will be obtained from Dr. Sam Telford from a laboratory maintained tick colony at Tufts Veterinary School. These ticks are hatched from eggs laid by ticks that have fed only on specific pathogen free laboratory animals that were purchased from established vendors. Between 25-30 larval ticks that have been aged and are known to be ready to attach will be placed on the study participant.
Sponsors & Collaborators
- collaborator OTHER
-
Mansfield Family Practice LLC
collaborator OTHER -
Tufts Medical Center
collaborator OTHER -
New York Medical College
collaborator OTHER -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Adriana R Marques, M.D. · National Institute of Allergy and Infectious Diseases (NIAID)
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-24
- Primary Completion
- 2022-05-04
- Completion
- 2022-05-04
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease
NCT00000938 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
NCT00001101 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Diagnosis of Disseminated Lyme Borreliosis.
NCT04719962 ·Status: UNKNOWN ·Phase: NA
-
Next Generation Sequencing Detection of Lyme Disease
NCT03505879 ·Status: COMPLETED
-
Evaluation and Follow-up of People With Tick-borne Diseases
NCT04318925 ·Status: WITHDRAWN
-
Study and Treatment of Post Lyme Disease (STOP-LD)
NCT00000937 ·Status: COMPLETED ·Phase: PHASE3
-
Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease
NCT06611111 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Analysis of Lyme Disease Lesions
NCT00132327 ·Status: COMPLETED
-
Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis
NCT02553473 ·Status: COMPLETED ·Phase: PHASE3
-
Lyme Test Indication Combinations (LyTIC) Study
NCT03201042 ·Status: TERMINATED
-
Human Immune Response to Ixodes Scapularis Tick Bites
NCT05036707 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Anti-phospolipid Antibodies in Lyme Borreliosis
NCT06929546 ·Status: NOT_YET_RECRUITING
-
Ceftriaxone for Post-Treatment Lyme Disease
NCT06785402 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study of the Clinical, Microbiological and Epidemiological Characteristics of Recurrent Imported Borreliosis Confirmed by the CNR Borrelia
NCT07335965 ·Status: RECRUITING
-
Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
NCT03581279 ·Status: TERMINATED ·Phase: NA
-
Borrelia B-cell Diagnostics
NCT06045416 ·Status: RECRUITING
-
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
NCT05975099 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis
NCT00138801 ·Status: COMPLETED ·Phase: PHASE3
-
Lyme Disease Diagnostic Assay - Collection of Whole Blood
NCT05041595 ·Status: ENROLLING_BY_INVITATION
-
Understanding Tick-borne Diseases
NCT03501407 ·Status: UNKNOWN
-
Safety, Skin and Plasma Concentration of Azithromycin Dermal Formulation
NCT01243008 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase 1/2 Lyme Vaccine Study
NCT01504347 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Intervention in a Primary Healthcare Setting to Reduce Lyme Neuroborreliosis Treatment Delay
NCT03820999 ·Status: UNKNOWN ·Phase: NA
-
Tick-borne Encephalitis and Borrelial Antibodies in Serum
NCT03956446 ·Status: RECRUITING ·Phase: NA
-
Tick-borne Encephalitis and Positive Borrelial Antibodies
NCT02463942 ·Status: UNKNOWN ·Phase: NA